FARMINGTON HILLS, Mich.--(BUSINESS WIRE)--Precision IR, a Division of Michigan Healthcare Professionals, P.C., a medical practice specializing in vascular and interventional radiology, performed the first outpatient OBL (office-based lab) Y-90 radioembolization procedure in Michigan on Thursday, May 25, 2023.
To perform the procedure in an OBL setting, the facility must have the required imaging equipment and procedure rooms, along with the processes to safely handle nuclear materials. Clinical experience has shown that the vast majority of Y-90 radioembolization patients do not need to be kept overnight for observation; they are able to return home shortly after the two-hour procedure. In addition, a study published in September 2020 demonstrated that radioembolization procedures in the outpatient setting were safe, not subject to procedure delays common in hospitals and even had a shorter case duration.1
“Patients and their doctors now have state-of-the-art cancer treatment options outside of a traditional medical center,” says S. Andrew Vartanian, M.D., medical director of Precision IR. “This offers a number of benefits to patients, with a significant one being a lower overall cost of treatment.”
Ad Statistics
Times Displayed: 112342
Times Visited: 6716 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Y-90 stands for yttrium-90, a radioactive element with a very short half-life of approximately 2.5 days. It is a very precise radiation treatment that uses a liver tumor’s own blood supply to deliver radiation directly into the tumor, while minimizing damage to the surrounding, healthy tissue.
During the procedure, an interventional radiologist uses imaging to advance a very small catheter through the body’s blood vessels and into the branches of the hepatic artery that feed the liver tumor. Tiny radioactive beads (called Theraspheres®) are injected into the microvasculature surrounding the tumor where they become lodged, block the blood flow to the tumor, and release radiation.
While Y-90 is not a cure for liver cancer, it can eliminate or slow the growth of tumors and extend and/or improve the patient’s quality of life. It is an especially important treatment option for those with inoperable liver tumors, or tumors that have grown into major blood vessels or other vital structures which make surgical removal of the tumors impractical or impossible.
Dr. Vartanian and his team at Precision IR perform a wide range of minimally invasive treatments, from several types of cancer treatment to treatments for enlarged prostate, uterine fibroids, spine fractures and knee pain caused by osteoarthritis.
